Logo image of AGH

AUREUS GREENWAY HOLDINGS INC (AGH) Stock Fundamental Analysis

NASDAQ:AGH - Nasdaq - US05156D1028 - Common Stock - Currency: USD

0.6951  +0.1 (+16.16%)

After market: 0.6801 -0.02 (-2.16%)

Fundamental Rating

1

Overall AGH gets a fundamental rating of 1 out of 10. We evaluated AGH against 0 industry peers in the Unkown industry. AGH may be in some trouble as it scores bad on both profitability and health. AGH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AGH had positive earnings in the past year.
AGH Yearly Net Income VS EBIT VS OCF VS FCFAGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 200K 400K 600K 800K

1.2 Ratios

The 3 year average ROIC (13.40%) for AGH is well above the current ROIC(9.16%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 7.2%
ROE 29.67%
ROIC 9.16%
ROA(3y)7.3%
ROA(5y)N/A
ROE(3y)40.41%
ROE(5y)N/A
ROIC(3y)13.4%
ROIC(5y)N/A
AGH Yearly ROA, ROE, ROICAGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 10 20 30 40 50

1.3 Margins

Industry RankSector Rank
OM 7.12%
PM (TTM) 10.86%
GM 58.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AGH Yearly Profit, Operating, Gross MarginsAGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 10 20 30 40 50

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, AGH has about the same amount of shares outstanding.
Compared to 1 year ago, AGH has a worse debt to assets ratio.
AGH Yearly Shares OutstandingAGH Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M 10M
AGH Yearly Total Debt VS Total AssetsAGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 1M 2M 3M 4M

2.2 Solvency

Based on the Altman-Z score of 1.58, we must say that AGH is in the distress zone and has some risk of bankruptcy.
AGH has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 1.58
ROIC/WACCN/A
WACCN/A
AGH Yearly LT Debt VS Equity VS FCFAGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 200K 400K 600K 800K 1M

2.3 Liquidity

A Current Ratio of 0.36 indicates that AGH may have some problems paying its short term obligations.
A Quick Ratio of 0.34 indicates that AGH may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.34
AGH Yearly Current Assets VS Current LiabilitesAGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

AGH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.01%, which is quite good.
The Revenue has grown by 18.15% in the past year. This is quite good.
EPS 1Y (TTM)13.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)18.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AGH Yearly Revenue VS EstimatesAGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 1M 2M 3M
AGH Yearly EPS VS EstimatesAGH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.17, AGH is valued on the expensive side.
Compared to an average S&P500 Price/Earnings ratio of 29.35, AGH is valued a bit cheaper.
Industry RankSector Rank
PE 23.17
Fwd PE N/A
AGH Price Earnings VS Forward Price EarningsAGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.91
AGH Per share dataAGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1 0.15 0.2 0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AGH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUREUS GREENWAY HOLDINGS INC

NASDAQ:AGH (3/7/2025, 8:03:58 PM)

After market: 0.6801 -0.02 (-2.16%)

0.6951

+0.1 (+16.16%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.65M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 23.17
Fwd PE N/A
P/S 2.71
P/FCF N/A
P/OCF N/A
P/B 7.41
P/tB 7.41
EV/EBITDA 21.91
EPS(TTM)0.03
EY4.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.26
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.2%
ROE 29.67%
ROCE 11.84%
ROIC 9.16%
ROICexc 11.98%
ROICexgc 11.98%
OM 7.12%
PM (TTM) 10.86%
GM 58.03%
FCFM N/A
ROA(3y)7.3%
ROA(5y)N/A
ROE(3y)40.41%
ROE(5y)N/A
ROIC(3y)13.4%
ROIC(5y)N/A
ROICexc(3y)22.42%
ROICexc(5y)N/A
ROICexgc(3y)22.42%
ROICexgc(5y)N/A
ROCE(3y)17.32%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 0.26
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.34
Altman-Z 1.58
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)100.27%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.3%
Cap/Sales(5y)N/A
Profit Quality(3y)124.17%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.15%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-45.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.23%
OCF growth 3YN/A
OCF growth 5YN/A